DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Pasi KJ, Fischer K, Ragni M. , et al.
Long-term safety and efficacy of extended-interval prophylaxis with recombinant factor IX Fc fusion protein (rFIXFc) in subjects with haemophilia B.
Thromb Haemost 2017;
117 (03) 508-518
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.